Literature DB >> 25829431

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD.

Bartolome R Celli1, Marc Decramer1, Jadwiga A Wedzicha1, Kevin C Wilson1, Alvar Agustí1, Gerard J Criner1, William MacNee1, Barry J Make1, Stephen I Rennard1, Robert A Stockley1, Claus Vogelmeier1, Antonio Anzueto1, David H Au1, Peter J Barnes1, Pierre-Regis Burgel1, Peter M Calverley1, Ciro Casanova1, Enrico M Clini1, Christopher B Cooper1, Harvey O Coxson1, Daniel J Dusser1, Leonardo M Fabbri1, Bonnie Fahy1, Gary T Ferguson1, Andrew Fisher1, Monica J Fletcher1, Maurice Hayot1, John R Hurst1, Paul W Jones1, Donald A Mahler1, François Maltais1, David M Mannino1, Fernando J Martinez1, Marc Miravitlles1, Paula M Meek1, Alberto Papi1, Klaus F Rabe1, Nicolas Roche1, Frank C Sciurba1, Sanjay Sethi1, Nikos Siafakas1, Don D Sin1, Joan B Soriano1, James K Stoller1, Donald P Tashkin1, Thierry Troosters1, Geert M Verleden1, Johny Verschakelen1, Jorgen Vestbo1, John W Walsh1, George R Washko1, Robert A Wise1, Emiel F M Wouters1, Richard L ZuWallack1.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity, mortality, and resource use worldwide. The goal of this official American Thoracic Society (ATS)/European Respiratory Society (ERS) research statement is to describe evidence related to diagnosis, assessment and management; identify gaps in knowledge; and make recommendations for future research. It is not intended to provide clinical practice recommendations on COPD diagnosis and management. Clinicians, researchers, and patient advocates with expertise in COPD were invited to participate. A literature search of Medline was performed, and studies deemed relevant were selected. The search was not a systematic review of the evidence. Existing evidence was appraised and summarised, and then salient knowledge gaps were identified. Recommendations for research that addresses important gaps in the evidence in all areas of COPD were formulated via discussion and consensus. Great strides have been made in the diagnosis, assessment and management of COPD, as well as understanding its pathogenesis. Despite this, many important questions remain unanswered. This ATS/ERS research statement highlights the types of research that leading clinicians, researchers, and patient advocates believe will have the greatest impact on patient-centred outcomes.
Copyright ©ATS/ERS 2015.

Entities:  

Mesh:

Year:  2015        PMID: 25829431     DOI: 10.1183/09031936.00009015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  47 in total

Review 1.  Optimizing Treatment of Elderly COPD Patients: What Role for Inhaled Corticosteroids?

Authors:  Andrea P Rossi; Erika Zanardi; Mauro Zamboni; Andrea Rossi
Journal:  Drugs Aging       Date:  2015-09       Impact factor: 3.923

2.  Accelerated extracellular matrix turnover during exacerbations of COPD.

Authors:  Jannie M B Sand; Alan J Knox; Peter Lange; Shu Sun; Jacob H Kristensen; Diana J Leeming; Morten A Karsdal; Charlotte E Bolton; Simon R Johnson
Journal:  Respir Res       Date:  2015-06-11

3.  Is COPD a Progressive Disease? A Long Term Bode Cohort Observation.

Authors:  Juan P de-Torres; Jose M Marín; Víctor Pinto-Plata; Miguel Divo; Pablo Sanchez-Salcedo; Jorge Zagaceta; Javier J Zulueta; Juan Berto; Carlos Cabrera; Bartolome R Celli; Ciro Casanova
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

4.  Screening for Chronic Obstructive Pulmonary Disease: Validity and Reliability of a Portable Device in Non-Specialized Healthcare Settings.

Authors:  Cristina Represas-Represas; Alberto Fernández-Villar; Alberto Ruano-Raviña; Ana Priegue-Carrera; Maribel Botana-Rial
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

Review 5.  Defining and targeting health disparities in chronic obstructive pulmonary disease.

Authors:  Roy A Pleasants; Isaretta L Riley; David M Mannino
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-10-04

6.  Sing Your Lungs Out-a community singing group for chronic obstructive pulmonary disease: a 1-year pilot study.

Authors:  Amanda McNaughton; Mark Weatherall; Mathew Williams; Harry McNaughton; Sarah Aldington; Gayle Williams; Richard Beasley
Journal:  BMJ Open       Date:  2017-01-24       Impact factor: 2.692

7.  Vital capacity and COPD: the Swedish CArdioPulmonary bioImage Study (SCAPIS).

Authors:  Kjell Torén; Anna-Carin Olin; Anne Lindberg; Jenny Vikgren; Linus Schiöler; John Brandberg; Åse Johnsson; Gunnar Engström; H Lennart Persson; Magnus Sköld; Jan Hedner; Eva Lindberg; Andrei Malinovschi; Eeva Piitulainen; Per Wollmer; Annika Rosengren; Christer Janson; Anders Blomberg; Göran Bergström
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-05-02

Review 8.  A review of national guidelines for management of COPD in Europe.

Authors:  Marc Miravitlles; Claus Vogelmeier; Nicolas Roche; David Halpin; João Cardoso; Alexander G Chuchalin; Hannu Kankaanranta; Thomas Sandström; Paweł Śliwiński; Jaromir Zatloukal; Francesco Blasi
Journal:  Eur Respir J       Date:  2016-01-21       Impact factor: 16.671

9.  Sing Your Lungs Out: a qualitative study of a community singing group for people with chronic obstructive pulmonary disease (COPD).

Authors:  Amanda McNaughton; Sarah Aldington; Gayle Williams; William M M Levack
Journal:  BMJ Open       Date:  2016-09-20       Impact factor: 2.692

10.  Defining obstructive ventilatory defect in 2015.

Authors:  Zied Affes; Salaheddine Rekik; Helmi Ben Saad
Journal:  Libyan J Med       Date:  2015-10-08       Impact factor: 1.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.